Abstract
Compelling evidence from randomized clinical trials has established the superiority of an early invasive over a conservative management strategy in patients presenting with non-ST-segment acute coronary syndromes, with a 20% to 40% reduction in recurrent ischemic events in patients undergoing routine early angiography and revascularization when appropriate. Those patients at high risk of death, recurrent myocardial infarction, or ischemia as indicated by elevated concentrations of cardiac troponin, ST-segment deviation, or high clinical risk score derive a greater clinical benefit from early invasive management than patients at lower risk who may be managed effectively with either strategy. Patients who have recurrent ischemia, infarction, hemodynamic instability, or a high-risk stress test should be considered for urgent catheterization regardless of the initial strategy chosen.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Current Treatment Options in Cardiovascular Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
